• Return to Headlines

28.0% Return Seen to Date on SmarTrend Repligen Corp Call (RGEN)

By Shiri Gupta

SmarTrend identified an Uptrend for Repligen Corp (NASDAQ:RGEN) on February 22nd, 2018 at $34.93. In approximately 4 months, Repligen Corp has returned 27.96% as of today's recent price of $44.69.

In the past 52 weeks, shares of Repligen Corp have traded between a low of $21.95 and a high of $46.81 and are now at $44.69, which is 104% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.4%.

Repligen Corporation is a bioprocessing company focused on the development, production and commercialization of innovative products used in the process of manufacturing biologic drugs. The Company's customers include life sciences companies, global biopharmaceutical companies, and contract manufacturers worldwide.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Repligen Corp shares.

Log in and add Repligen Corp (RGEN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights repligen corp

Ticker(s): RGEN